Evidence map›Paper›PMID 37620848›Full record

ArticleBMC complementary medicine and therapies2023

Evaluation of anti-quorum sensing and antibiofilm effects of secondary metabolites from Gambeya lacourtiana (De Wild) Aubr. & Pellegr against selected pathogens.

Rostan Mangoua Talla, Alfred Ngenge Tamfu, Brussine Nadège Kweka Wakeu, Ozgur Ceylan, Céline Djama Mbazoa, Gilbert Deccaux Wabo Fotso Kapche, Bruno Ndjakou Lenta, Norbert Sewald, Jean Wandji

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. A Glycolipid-Like Biosurfactant Molecule Derived From anInternational journal of microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Rostan Mangoua TallaDepartment of Organic Chemistry, Faculty of Science, The University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon.
Alfred Ngenge TamfuDepartment of Chemical Engineering, School of Chemical Engineering and Mineral Industries, University of Ngaoundéré, P.O. Box 454, Ngaoundéré, Cameroon. macntamfu@yahoo.co.uk.
Brussine Nadège Kweka WakeuDepartment of Organic Chemistry, Faculty of Science, The University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon.
Ozgur CeylanFood Quality Control and Analysis Program, Ula Ali Kocman Vocational School, Mugla Sitki Koc-man University, Mugla, 48147, Turkey.
Céline Djama MbazoaDepartment of Organic Chemistry, Faculty of Science, The University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon.
Gilbert Deccaux Wabo Fotso KapcheDepartment of Chemistry, Higher Teacher Training C ollege, The University of Yaoundé 1, P.O. Box 47, Yaoundé, Cameroon.
Bruno Ndjakou LentaDepartment of Chemistry, Higher Teacher Training C ollege, The University of Yaoundé 1, P.O. Box 47, Yaoundé, Cameroon.
Norbert SewaldChemistry Department, Organic and Bioorganic Chemistry, Bielefeld University, P.O. Box 100131, 33501, Bielefeld, Germany.
Jean WandjiDepartment of Organic Chemistry, Faculty of Science, The University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon.
Université de Yaoundé I · CMBielefeld University · DEMuğla University · TRUniversity of Ngaoundéré · CM

Funding

Deutscher Akademischer Austauschdienst 57316173
6 · The paper itself

Abstract

backgroundMicrobial infections cause serious health problems especially with the rising antibiotic resistance which accounts for about 700,000 human deaths annually. Antibiotics which target bacterial death encounter microbial resistance with time, hence, there is an urgent need for the search of antimicrobial substances which target disruption of virulence factors such as biofilm and quorum sensing (QS) with selective pressure on the pathogens so as to avoid resistance.

methodsNatural products are suitable leads for antimicrobial drugs that can inhibit bacterial biofilms and QS. Twenty compounds isolated from the medicinal plant Gambeya lacourtiana were evaluated for their antibiofilm and anti-quorum sensing effects against selected pathogenic bacteria.

resultsMost of the compounds inhibited violacein production in Chromobacterium violaceum CV12472 and the most active compound, Epicatechin had 100% inhibition at MIC (Minimal Inhibitory Concentration) and was the only compound to inhibit violacein production at MIC/8 with percentage inhibition of 17.2 ± 0.9%. Since the bacteria C. violaceum produces violacein while growing, the inhibition of the production of this pigment reflects the inhibition of signal production. Equally, some compounds inhibited violacein production by C. violaceum CV026 in the midst of an externally supplied acylhomoserine lactone, indicating that they disrupted signal molecule reception. Most of the compounds exhibited biofilm inhibition on Staphyloccocus aureus, Escherichia coli and Candida albicans and it was observed that the Gram-positive bacteria biofilm was most susceptible. The triterpenoids bearing carboxylic acid group, the ceramide and epicatechin were the most active compounds compared to others.

conclusionSince some of the compounds disrupted QS mediated processes in bacteria, it indicates that this plant is a source of antibiotics drugs that can reduce microbial resistance.

Indexed as

Biological ProductsCatechinAcyl-ButyrolactonesAnti-Bacterial AgentsBiofilmsEscherichia coliHumansAcyl-ButyrolactonesAnti-Bacterial AgentsBiological ProductsCatechinAntibiofilm activityAntimicrobialsG. lacourtianaQuorum-sensing inhibitionSecondary metabolitesSwarming motility inhibition

Identifiers

PMID37620848
PMCPMC10464238
OpenAlexW4386120655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.